Business Wire (May 10, 2013)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Business Wire (May 8, 2013)
-
-
-
Business Wire (May 2, 2013)
-
-
Business Wire (Apr 2, 2013)
-
-
Business Wire (Mar 19, 2013)
-
-
-
Business Wire (Mar 6, 2013)
-
-
Business Wire (Feb 20, 2013)
-
-
Business Wire (Feb 5, 2013)
-
-
-
-
To learn more about Seeking Alpha Pro, click here.
-
CombinatoRx, Inc. Q4 2009 Earnings Call TranscriptThu, Mar 25, 2010
-
CombinatoRx, Inc. Q2 2009 Earnings Call TranscriptMon, Aug 10, 2009
-
CombinatoRx, Inc., Q4 2008 Earnings Call TranscriptWed, Mar 4, 2009
-
CombinatoRx, Inc. Q4 2007 Earnings Call TranscriptWed, Mar 19, 2008
-
Business Wire (May 10, 2013)
-
Business Wire (May 8, 2013)
-
Business Wire (May 2, 2013)
-
Business Wire (Apr 2, 2013)
-
Business Wire (Mar 19, 2013)
-
Business Wire (Mar 6, 2013)
-
Business Wire (Feb 20, 2013)
-
Business Wire (Feb 5, 2013)
-
Business Wire (Jan 3, 2013)
-
Business Wire (Dec 5, 2012)
-
Business Wire (Nov 27, 2012)
-
Business Wire (Nov 8, 2012)
-
Business Wire (Oct 25, 2012)
-
Business Wire (Sep 10, 2012)
-
at Fox Business (Aug 27, 2012)
-
Business Wire (Aug 27, 2012)
-
Business Wire (Aug 8, 2012)
-
Business Wire (Aug 7, 2012)
-
Business Wire (Jul 10, 2012)
ZLCS vs. ETF Alternatives
Company Description
We are a biopharmaceutical company pioneering the field of synergistic combination pharmaceuticals. Going beyond traditional combinations, we use our innovative drug discovery technology to create product candidates with novel multi-target mechanisms of action striking at the biological... More
